12th International Congress on Myeloproliferative Neoplasms

 

12th International Congress on Myeloproliferative Neoplasms
R

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies Targeting Mutant CALR in ET, Targeting TGF-B1 and NF-kB-Activation in MF

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Ronald Hoffman
By 12th International Congress on Myeloproliferative Neoplasms FEATURING Ronald Hoffman
21 views
November 25, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Latest Advances in Myeloproliferative Neoplasms
19:58
12th International Congress on Myeloproliferative Neoplasms

How Should We Treat Children w/ MPN: No Guidelines on Cytoreduction …

Feat. N. Kucine
22:49

Old and New Myelofibrosis (MF) Classifications, When to Consider Tra…

12th International Congress on Myeloproliferative Neoplasms

H. Deeg

34 views
28:48

Introduction to Hypoxia and Erythropoiesis in the Context of High Al…

12th International Congress on Myeloproliferative Neoplasms

J. Prchal

32 views
26:03

Moving Beyond JAKi: Ruxolitinib Failure, Newly Approved and in Devel…

12th International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

114 views
28:30

Is There a Role of Transplantation for CML in the Era of TKIs?

12th International Congress on Myeloproliferative Neoplasms

K. Van Besien

21 views
16:32

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Ou…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

19 views
08:25

What is the Molecular Landscape of Blast Phase MPN and the Implicati…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

17 views
06:52

Targeting Dysregulated Iron Metabolism in Polycythemia Vera (PV) Pat…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

17 views
08:25

Therapeutic Options for Treating MPNs are Finally Expanding: Targeti…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

164 views
11:27

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies …

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

21 views
17:00

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-F…

12th International Congress on Myeloproliferative Neoplasms

R. Silver

22 views
07:54

Update on Long Acting Interferons in MPN: Who Should Be Treated, Who…

12th International Congress on Myeloproliferative Neoplasms

H. Gisslinger

23 views
25:17

Wrangling the MPN-Related Symptom Burden: Specific Symptoms and Etio…

12th International Congress on Myeloproliferative Neoplasms

R. Scherber

169 views
26:23

Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subty…

12th International Congress on Myeloproliferative Neoplasms

A. Klion

34 views
30:14

Tales from the Clinic on Essential Thrombocytosis: No Therapy for As…

12th International Congress on Myeloproliferative Neoplasms

J. Spivak

51 views
13:55

Review of JAK2V617F and the Concept of the VAF

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

21 views
20:40

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP:…

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

24 views